DTC provides a turnkey arrhythmia monitoring program—not just a device—designed to deliver continuous, high-quality cardiac data with minimal staff involvement and maximum clinical reliability. By combining wearable technology, real-time analytics, and rapid reporting, providers can identify cardiac risk earlier, improve patient compliance, and capture additional reimbursable services without disrupting their existing workflow. 

Smart Wearable Biosensors

Our cutting-edge wearable biosensor patch is applied to the chest and provides high-quality ECG measurements.  Our cardiovascular solution focuses on providing near flawless and wireless ECG signal continuously for up to 30-days, with most tests not lasting more than 10 – 14 days due to the high diagnostic yield provided on the cardiovascular platform. Diabetes Testing Centers™ (DTC) delivers a modern, turnkey approach to arrhythmia detection through advanced wearable biosensor and watch-based monitoring—designed to fit seamlessly into existing clinical workflows while enhancing both patient experience and clinical outcomes.

Our platform enables continuous, high-fidelity cardiac monitoring in a format that is simple to deploy, comfortable for patients, and scalable across a variety of care settings—including in-clinic, remote, and mobile environments. Whether monitoring for a single day or extended periods up to 30 days, providers benefit from a streamlined process that minimizes staff burden while maximizing diagnostic yield.

Clinicians are equipped with secure, real-time access to patient data through a cloud-based platform, allowing for immediate visibility into cardiac activity and timely clinical decision-making. The system is supported by advanced AI-driven arrhythmia detection algorithms, delivering highly accurate, clinically actionable insights with rapid report turnaround times.

Unlike traditional monitoring solutions that rely on delayed processing or fragmented data capture, DTC’s approach ensures continuous 24/7 ECG data acquisition with no signal gaps, no device fall-off issues, and minimal risk of skin irritation—resulting in higher patient compliance and more reliable outcomes.

Each monitoring episode is delivered as a complete, end-to-end service—from device deployment to final report—supporting providers with efficient documentation, improved workflow integration, and alignment with reimbursable cardiac monitoring pathways.

We see and watch every beat, and so can you through your secure portal with Unfiltered Full Disclosure.